These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31971034)

  • 21. Apremilast as a target therapy for nail psoriasis: a real-life observational study proving its efficacy in restoring the nail unit.
    Lanna C; Cesaroni GM; Mazzilli S; Vollono L; Gaziano R; Marino D; Bianchi L; Campione E
    J Dermatolog Treat; 2022 Mar; 33(2):1097-1101. PubMed ID: 32715817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NAPSI utilization as an evaluation method of nail psoriasis in patients using acitretin.
    Mukai MM; Poffo IF; Werner B; Brenner FM; Lima Filho JH
    An Bras Dermatol; 2012; 87(2):256-62. PubMed ID: 22570030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study.
    Rigopoulos D; Gregoriou S; Stratigos A; Larios G; Korfitis C; Papaioannou D; Antoniou C; Ioannides D
    Br J Dermatol; 2008 Aug; 159(2):453-6. PubMed ID: 18565184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the efficacy of acitretin therapy for nail psoriasis.
    Tosti A; Ricotti C; Romanelli P; Cameli N; Piraccini BM
    Arch Dermatol; 2009 Mar; 145(3):269-71. PubMed ID: 19289755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of baseline disease severity on achievement of treatment target with apremilast: results from a pooled analysis.
    Reich K; Mrowietz U; Menter A; Griffiths CEM; Bagel J; Strober B; Nunez Gomez N; Shi R; Guerette B; Lebwohl M
    J Eur Acad Dermatol Venereol; 2021 Dec; 35(12):2409-2414. PubMed ID: 34255891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of psoriatic nails with indigo naturalis oil extract: a non-controlled pilot study.
    Lin YK; See LC; Chang YC; Huang YH; Chen JL; Tsou TC; Leu YL; Shen YM
    Dermatology; 2011; 223(3):239-43. PubMed ID: 22056841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adalimumab for the treatment of moderate to severe psoriasis: subanalysis of effects on scalp and nails in the BELIEVE study.
    Thaçi D; Unnebrink K; Sundaram M; Sood S; Yamaguchi Y
    J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):353-360. PubMed ID: 24846518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ustekinumab in nail psoriasis: an open-label, uncontrolled, nonrandomized study.
    Patsatsi A; Kyriakou A; Sotiriadis D
    J Dermatolog Treat; 2013 Apr; 24(2):96-100. PubMed ID: 21797806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of NAPSI and N-NAIL for evaluation of fingernail psoriasis in patients with moderate-to-severe plaque psoriasis treated using ustekinumab.
    Kim BR; Yang S; Choi CW; Youn SW
    J Dermatolog Treat; 2019 Mar; 30(2):123-128. PubMed ID: 29757042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the Intralesional Forms of Methylprednisolone Acetate and Methotrexate on Psoriatic Nails.
    Kassem R; Gupta AK; Bamimore MA; Talukder M; Shemer A; Magal L; Lyakhovitsky A; Daniel R; Kaplan B; Galili E
    Skinmed; 2024; 22(1):35-39. PubMed ID: 38494613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel transdermal device for delivery of triamcinolone for nail psoriasis treatment.
    Yew YW; Phuan CZY; Zhao X; Tan EST; Chong WS; Tey HL
    Ann Acad Med Singap; 2022 Jan; 51(1):16-23. PubMed ID: 35091727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical parameters associated with severity of nail psoriasis and therapeutic efficacy.
    You Z; Yang H; Ran Y
    Eur J Dermatol; 2020 Aug; 30(4):362-371. PubMed ID: 32969797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative Study of Clinical and Dermoscopic Features in Nail Psoriasis.
    Wanniang N; Navya A; Pai V; Ghodge R
    Indian Dermatol Online J; 2020; 11(1):35-40. PubMed ID: 32055506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small molecule inhibitors and biologics in treating nail psoriasis: A systematic review and network meta-analysis.
    Huang IH; Wu PC; Yang TH; Li H; Huang YT; Cheng YC; Kuo PH; Lee YH; Huang YC; Tu YK
    J Am Acad Dermatol; 2021 Jul; 85(1):135-143. PubMed ID: 33482253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of secukinumab on the clinical activity and disease burden of nail psoriasis: 32-week results from the randomized placebo-controlled TRANSFIGURE trial.
    Reich K; Sullivan J; Arenberger P; Mrowietz U; Jazayeri S; Augustin M; Parneix A; Regnault P; You R; Milutinovic M
    Br J Dermatol; 2019 Nov; 181(5):954-966. PubMed ID: 30367462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 36-week retrospective open trial comparing the efficacy of biological therapies in nail psoriasis.
    Bardazzi F; Antonucci VA; Tengattini V; Odorici G; Balestri R; Patrizi A
    J Dtsch Dermatol Ges; 2013 Nov; 11(11):1065-70. PubMed ID: 24119121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the efficacy of methotrexate and cyclosporine therapies on psoriatic nails: a one-blind, randomized study.
    Gümüşel M; Özdemir M; Mevlitoğlu I; Bodur S
    J Eur Acad Dermatol Venereol; 2011 Sep; 25(9):1080-4. PubMed ID: 21118309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nail Psoriasis: An Updated Review and Expert Opinion on Available Treatments, Including Biologics.
    Bardazzi F; Starace M; Bruni F; Magnano M; Piraccini BM; Alessandrini A
    Acta Derm Venereol; 2019 May; 99(6):516-523. PubMed ID: 30521057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The comparison of Nail Psoriasis Severity Index with a less time-consuming qualitative system.
    Kaçar N; Ergin S; Erdoğan BS
    J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):219-22. PubMed ID: 18211416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2).
    Rich P; Gooderham M; Bachelez H; Goncalves J; Day RM; Chen R; Crowley J
    J Am Acad Dermatol; 2016 Jan; 74(1):134-42. PubMed ID: 26549249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.